Colony stimulating factor-1 (CSF-1) signalling is predictive of response to immune checkpoint inhibitors in advanced non-small cell lung cancer - Biomarqueurs et Essais Cliniques en Cancérologie et Onco-Hématologie
Article Dans Une Revue Lung Cancer Année : 2024

Colony stimulating factor-1 (CSF-1) signalling is predictive of response to immune checkpoint inhibitors in advanced non-small cell lung cancer

Fichier principal
Vignette du fichier
1-s2.0-S0169500223009856-main.pdf (2.17 Mo) Télécharger le fichier
Origine Publication financée par une institution
licence

Dates et versions

hal-04517531 , version 1 (07-06-2024)

Licence

Identifiants

Citer

Paul Takam Kamga, Marie Mayenga, Louise Sebane, Adrien Costantini, Catherine Julie, et al.. Colony stimulating factor-1 (CSF-1) signalling is predictive of response to immune checkpoint inhibitors in advanced non-small cell lung cancer. Lung Cancer, 2024, 188, pp.107447. ⟨10.1016/j.lungcan.2023.107447⟩. ⟨hal-04517531⟩
103 Consultations
33 Téléchargements

Altmetric

Partager

More